Exodus Point Capital Management, LP Senseonics Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.55 - $0.89 $28,116 - $45,496	51,120 New	51,120 $39,000
Q1 2022 May 13, 2022	SELL	$1.54 - $3.71 $95,212 - $229,374	-61,826 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.58 - $3.91 $159,511 - $241,739	61,826 New	61,826 $165,000
Q1 2021 May 17, 2021	SELL	$0.85 - $5.27 $255,470 - $1.58 Million	-300,554 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$0.36 - $0.95 $72,945 - $192,494	-202,626 Reduced 40.27%	300,554 $262,000

Q3 2020 Nov 16, 2020	BUY	$0.36 - $0.53 $181,144 - $266,685	503,180 New	503,180 $195,000
Q2 2020 Aug 14, 2020	SELL	$0.39 - $0.69 $5,964 - $10,552	-15,294 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.56 - $1.62 $8,564 - $24,776	15,294 New	15,294 $10,000

148

66.3M

392K

207K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $182M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.